<DOC>
	<DOCNO>NCT02643446</DOCNO>
	<brief_summary>The Purpose study ass seroconversion use inactivated poliovirus vaccine ( IPV ) oral poliovirus vaccine ( OPV ) sequential schedule pilot area IPV phase introduce national immunization program ( NIP ) China .</brief_summary>
	<brief_title>Serological Survey Monitoring Positive Rate After Vaccination Inactivated Polio Vaccine</brief_title>
	<detailed_description>Objective : 1 . To evaluate seroprotection rate 3 dos primary polio vaccination among age eligible child pilot area IPV introduce NIP ; 2 . To evaluate seroprotection rate different dose ( ) polio vaccine ( ) use sequential schedule . Sample size:752 1 . Jilin shall select 120 subject collect blood sample evaluation immune response , 90 give OPV second vaccine 30 give IPV second vaccine 2 . Hubei shall select 132 subject collect blood sample evaluation immune response , 102 give OPV second vaccine 30 give IPV second vaccine 3 . Ningxia shall select 260 subject collect blood sample evaluation immune response . The subject divide 5 group . 4 . In Guangdong province,120 child select subject , 80 child give OPV first vaccine 40 child give IPV first vaccine . 5 . Tianjin shall select 120 subject collect blood sample evaluation immune response , 80 give OPV second vaccine 30 give IPV second vaccine Organization Chart Study : - Chinese Centers Disease Control Prevention ( China CDC ) lead overall study , responsible study design , supervise five select province , conduct field monitor , data analysis result distribution explanation . - The five pilot Provincial CDCs conduct supervision monitor 1-2 county CDCs pilot province . - The County CDCs organize several vaccination clinic recruit subject meet Inclusion criterion . Quality Assurance Plan : - China CDC provincial CDC monitor supervise field work , ensure quality study . - County CDCs organize vaccination clinic service subject receive timely polio vaccine accordance immunization schedule , blood sample collect accordance require timeline difference group . - Clinic doctor communicate explain purpose procedure survey parent , sign informed consent parent obtain child participate study . - The target drop-out rate subject without second blood sample province less 10 % . - The sample test polio antibody qualify laboratory , World Health Organization certify polio network laboratory China .</detailed_description>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child regular resident pilot county immune response evaluate pilot province . Receiving polio vaccination 2 , 3 4 month old interval 2835 day dose accord national immunization schedule . The first dose vaccine administer 2 full month old less 3 full month old . No rotavirus vaccine administer period primary polio vaccination , vaccine category 2 ( private market ) administer simultaneously polio vaccine . If vaccine category 2 rotavirus vaccine administer , administered space least 2 week polio vaccination . The first dose polio vaccine administer 3 month old regardless reason . Children n't get proper type dos vaccine protocal require . Children known immunodeficiency condition . Immunosuppressive agent blood product use birth . Vaccine contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Poliovirus Vaccine , Inactivated</keyword>
	<keyword>Poliovirus Vaccine , Oral</keyword>
	<keyword>Immunity</keyword>
	<keyword>Seroconversion</keyword>
</DOC>